IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone
Phillips, L. D., Amzal, B., Asiimwe, A., Chan, E., Chen, C., Hughes, D., Juhaeri, J., Micaleff, A., Mt-Isa, S., Noel, B., +2 more...Shepherd, S. & Wang, N.
(2013).
IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone.
PROTECT Consortium.
| Item Type | Report (Technical Report) |
|---|---|
| Copyright holders | © 2013 PROTECT Consortium |
| Departments | LSE > Academic Departments > Management |
| Date Deposited | 10 Dec 2015 |
| URI | https://researchonline.lse.ac.uk/id/eprint/64646 |